Phase I Study of A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose Escalation Study in Healthy Volunteers to Evaluate The Safety, Tolerability and Pharmacokinetics Following Escalating Single and Multiple Doses Administered as Topical Application.
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Ibuprofen (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Tianjin XinChen-Techfields Pharma
- 05 Dec 2017 Status changed from recruiting to completed.
- 30 Jun 2016 Planned primary completion date changed from 1 Dec 2016 to 1 May 2017.
- 15 Jun 2016 New trial record